1 Sept 2026
Mutant isocitrate dehydrogenase in cancer: Structural biology, small-molecule inhibitors, and future drug discovery strategiesPublisher siteDrug Discovery Today, Colorectal Cancer Treatments and Studies
Active, last published 2026
In synthesis and catalytic reactions
Salma M.
Hefny
Scholar“Research focused on Synthesis and Catalytic Reactions and adjacent fields.”
Tanta University
Egypt
Claim Your ProfileEgypt5
H-index
172
Citations
Salma has not officially claimed their profile. If you are Salma, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
alma M. Hefny is a researcher working on Synthesis and Catalytic Reactions. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Salma's work has been cited 172 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and Catalytic Reactions×4Enzyme function and inhibition×4Cholinesterase and Neurodegenerative Diseases×3Synthesis and biological activity×2
04 · Where I am
Affiliations
Affiliation on published researchTanta University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works28 May 2026
Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP‐1/EGFR InhibitorsPublisher siteDrug Development Research, PARP inhibition in cancer therapy
5 Mar 2026
Biphenyl urea derivatives as novel GPX4 inhibitors: ferroptosis-mediated antiproliferative activity against CNS cancer cellsPublisher siteBioorganic Chemistry, Ferroptosis and cancer prognosis
6 Aug 202411cites
Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agentsPublisher siteBioorganic Chemistry, Synthesis and biological activity
24 May 2024Open access35cites
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessmentsPublisher siteEuropean Journal of Medicinal Chemistry, Enzyme function and inhibition
20 Apr 2024Open access32cites
Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, <i>In Vitro</i>, <i>In Vivo</i>, and <i>In Silico</i> Investigations of Coumarin-Based ThiazolesPublisher siteJournal of Medicinal Chemistry, Enzyme function and inhibition
26 Mar 202413cites
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulationsPublisher siteJournal of Molecular Structure, Enzyme function and inhibition
11 Jan 2024Open access29cites
Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of GlaucomaPublisher siteJournal of Medicinal Chemistry, Enzyme function and inhibition
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Salma?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you